Advertisement

Topics

Key Drug Prototyping Company Profile

12:41 EDT 20th September 2017 | BioPortfolio

KeyDP develops new drugs based on the atomic details of the proteins that they target. KeyDP focuses on carefully identified targets with good drug potential. To this aim, KeyDP establishes strategic partnerships to complement its own focus on the molecular aspects of drug design and development. Our technology and business model will allow us to develop drugs faster and cheaper than current practice with a dramatically higher survival rate of leads becoming drugs.

Location

Einsteinweg
Leiden
2333 CC
Netherlands

Contact

Phone: +31-71-527-4414
Fax: +31-71-527-4357
Email: keydp@keydp.com


News Articles [2435 Associated News Articles listed on BioPortfolio]

Revolutionary Medical Devices

As prototyping technologies and practices advance, the medical industry is seeing an influx of devices that offer a variety of benefits from improved sanitation to... Read More →

FDA Approves First New ALS Drug in More than 20 Years

NewsThe Food and Drug Administration has approved the drug Radicava, also known as edaravone, for the treatment for amyotrophic lateral sclerosis (ALS). This is the first time an ALS drug has been cl...

FDA Asks Drug Company to Pull Painkiller in First

The U.S. Food and Drug Administration (FDA) announced today (June 8) that it has requested that Endo Pharmaceuticals, a drug company, remove the opioid painkiller Opana ER from the drug market. This ...

FDA Approves First New Drug to Treat ALS in 20 Years – WRAL.com

WRAL.comFDA Approves First New Drug to Treat ALS in 20 YearsWRAL.comThe Food and Drug Administration said Friday it had approved the first new drug in 20 years to treat the paralyzing disease ALS. The...

FDA Approves First New Drug to Treat ALS in 20 Years – NBCNews.com

NBCNews.comFDA Approves First New Drug to Treat ALS in 20 YearsNBCNews.comThe Food and Drug Administration said Friday it had approved the first new drug in 20 years to treat the paralyzing disease AL...

At $475,000, new cancer drug raises thorny questions about drug pricing — and value

Pricing for the Novartis drug, which treats an aggressive form of childhood leukemia, has stirred the heated national debate over prescription drug costs.

New Method Yields Shortcut in Drug Development

NewsThe majority of promising new drug candidates are effective only within the body’s cells, but quick general methods of determining intracellular drug quantities are lacking.

France to prosecute its drug regulator and Servier in scandal over diabetes drug

France’s drug regulator and one of its leading drug companies, Servier, will stand trial as legal persons over the marketing of the antidiabetes and weight loss drug benfluorex (marketed in France a...

Drugs and Medications [0 Results]

None

PubMed Articles [2844 Associated PubMed Articles listed on BioPortfolio]

Prototyping for the treatment of late zygomatic-orbital fracture: A case report.

Zygomatic-orbital complex fractures are the most common facial traumas that can result in severe esthetic and functional sequelae. Surgical correction of these fractures is a delicate approach and pro...

Preliminary Clinical Application of Removable Partial Denture Frameworks Fabricated Using Computer-Aided Design and Rapid Prototyping Techniques.

The aim of this study was to explore the application of computer-aided design and rapid prototyping (CAD/RP) for removable partial denture (RPD) frameworks and evaluate the fitness of the technique fo...

Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions.

Knowledge about drug-drug interactions commonly arises from preclinical trials, from adverse drug reports, or based on knowledge of mechanisms of action. Our aim was to investigate whether drug-drug i...

Identification of drug- and drug-metabolite immune responses originating from both naïve and memory T-cells.

Both naïve and memory T-cells from drug-naive donors can be stimulated by parent drug and drug haptens. Thus, drug-derived antigens can stimulate naïve T-cells alongside pre-existing memory T-cells ...

Pen-on-paper strategy for point-of-care testing: Rapid prototyping of fully written microfluidic biosensor.

Paper-based microfluidic biosensors have recently attracted increasing attentions in point-of-care testing (POCT) territories benefiting from their affordable, accessible and eco-friendly features, wh...

Clinical Trials [1858 Associated Clinical Trials listed on BioPortfolio]

Rapid Prototyping Models for Patient Education

Pre-made rapid prototyping models will be used to increase patient education versus current methodologies.

Biomodel in Tetralogy of Fallot

Using biocardiac model in helping the total correction of the Tetralogy of Fallot.

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session...

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent

Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions

The investigators hypothesize that in a real-world population undergoing percutaneous coronary intervention (PCI) for de-novo stenoses in small native vessels with a diameter

Companies [1250 Associated Companies listed on BioPortfolio]

Plastic Technologies, Inc.

Plastic Technologies, Inc. is recognized worldwide as the preferred source for preform and package design, package development, rapid prototyping, pre-production prototyping, and material evaluation e...

Key Drug Prototyping

KeyDP develops new drugs based on the atomic details of the proteins that they target. KeyDP focuses on carefully identified targets with good drug potential. To this aim, KeyDP establishes strategic ...

Turner MedTech

As an organization, Turner Innovations (R&D) and Turner MedTech (manufacturing) combine to serve as one of the nation’s most highly-specialized resources for the commercializ...

The Technology House

Established in 1996, The Technology House is a leading provider of product engineering, computer-aided design and manufacturing (CAD/CAM), product development, and rapid prototypi...

Key Drug Prototyping BV

KeyDP was founded in November 2001 by Flip Hoedemaeker, Jan Pieter Abrahams and Hans van Beek. Since our inception, we have been a private, independent income generating company. Our team believes in ...

More Information about "Key Drug Prototyping" on BioPortfolio

We have published hundreds of Key Drug Prototyping news stories on BioPortfolio along with dozens of Key Drug Prototyping Clinical Trials and PubMed Articles about Key Drug Prototyping for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Key Drug Prototyping Companies in our database. You can also find out about relevant Key Drug Prototyping Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record